AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
New spending habits require responsive budgeting. Implement flexible rules that accommodate changes while protecting savings and debt targets.
25,665 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Verizon fell today after a day of headline-driven moves, including strategic spin-offs and competitive shifts in the ...
After 15 years of bullish calls on banks, a veteran analyst pivots to private equity and other alternatives, downgrad...
NOBLE publicly endorses the CLARITY Act, while Major County Sheriffs of America move to neutral after talks on Sectio...
A stock can jump this year, but chasing it blindly rarely ends well. This guide helps you assess whether the move jus...
Pi Network’s PI tumbles to a fresh all-time low as a 130 million token unlock looms, signaling potential further down...
Dogecoin remains near key support as the Musk-and-SpaceX narrative cools. Investors await fresh catalysts that could ...
Bloom Energy has surged in 2026 on AI infrastructure bets, but a July pullback raises questions about the stock's nex...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Coinbase faces a volatile crypto backdrop, but a broader push into institutional services and fintech partnerships co...
Hillary Clinton testifies in New York as part of a House probe into Jeffrey Epstein, with Bill Clinton expected to fo...
The 2026 mortgage update signals a turning tide for borrowers. Lower rates and the return of adjustable-rate mortgage...